FindMyKOL
Clinical trialNCT02377180CompletedInterventional

Capsaicin-induced Muscle Pain in Humans

SponsorInsel Gruppe AG, University Hospital BernEnrollment72Healthy
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

There is currently no specific diagnostic test for primary muscular pain. The present study investigates whether selective blockade of the suprascapular nerve can effectively abolish experimental pain arising from the supraspinatus muscle. Experimental muscle pain is induced by intramuscular injection of capsaicin, an alkaloid from red chili peppers. The study consists of three parts: 1. to describe the development, time course and intensity of capsaicin-induced muscle pain 2. to evaluate the effectiveness of suprascapular nerve block against capsaicin-induced muscle pain 3. to compare suprascapular nerve block and direct intramuscular local anesthetic infiltration for their effectiveness in capsaicin-induced muscle pain

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • Michele Curatolo, M.D., Ph.D.

    Department of Anesthesiology and Pain Therapy, University of Washington, Seattle WA, USA

    Study Chair

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Switzerland
  • University Department of Anesthesiology and Pain Therapy,inselspital Bern

    Bern, Canton of Bern, Switzerland

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2014
Primary completion
31 Dec 2016
Completion
31 Dec 2016
Last update posted
18 Jan 2017
Registered enrollment
72
Registry id
NCT02377180

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.